Natco Pharma hikes investment in US-based eGenesis to $16.7 million

Under the revised structure, Natco Pharma (Canada) Inc will invest $13.70 million, while Natco Pharma USA LLC will contribute $3 million, according to a regulatory filing
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.